Beth Israel Deaconess Medical Center and Cancer Genetics Inc. enter collaboration

At confirmation hearing, Heidi Overton sidesteps questions about FDA regulation of fruit-flavored vapes

Heidi Overton, President Trump’s nominee for FDA Commissioner, defended the agency’s recent policy decisions reversing its hardball stance on flavored nicotine products, as she appeared in front of the Senate Committee on Health, Education, Labor, and Pensions on Sept 24.

September 25, 2026

By Sara Willa Ernst

Cancer Policy

Trump administration pulls 750,000 people from ACA coverage, claiming fraud

The Trump administration has announced the removal of 750,000 people from coverage on the Affordable Care Act marketplace. Vice President JD Vance asserted that these individuals are suspected of “fraudulently enrolling in the program.”

September 25, 2026

By Sara Willa Ernst

Cancer Policy

HHS issues direct final rule to reduce reliance on animal testing

FDA has issued a direct final rule that changes the language in its regulations so that “animal testing” is no longer described as the default or defining form of “nonclinical” safety testing.

September 25, 2026

By Claire Marie Porter

Cancer Policy

NCI launches AI tool to help match patients to clinical trials

NCI Director Anthony Letai announced the development of TrialMatch, an AI tool that helps oncologists identify clinical trials for their patients.

September 25, 2026

By Sara Willa Ernst

Cancer Policy

EPA stops publishing air pollution cancer risk data

EPA has stopped publishing cancer risk estimates as part of its annual Air Toxics Screening Assessment, according to a team of data scientists and former federal employees at the Federation of American Scientists. The group has tracked hundreds of federal databases that have disappeared—in part or in full—since the start of the second Trump administration.

September 25, 2026

By Sara Willa Ernst

Podcast

36 months to live, 29 months to wait. Why is Congress withholding lifesaving benefits from breast cancer patients?

In this episode of The Cancer Letter Podcast, Fran Visco, president of the National Breast Cancer Coalition, and Jacquelyn Cobb, managing editor of The Cancer Letter, discuss the Metastatic Breast Cancer Act, bipartisan legislation that would eliminate the waiting periods for Social Security Disability Insurance and Medicare for eligible people with metastatic breast cancer.

September 23, 2026

Beth Israel Deaconess Medical Center and Cancer Genetics Inc. enter collaboration

YOU MAY BE INTERESTED IN

At confirmation hearing, Heidi Overton sidesteps questions about FDA regulation of fruit-flavored vapes

Trump administration pulls 750,000 people from ACA coverage, claiming fraud

HHS issues direct final rule to reduce reliance on animal testing

NCI launches AI tool to help match patients to clinical trials

EPA stops publishing air pollution cancer risk data

36 months to live, 29 months to wait. Why is Congress withholding lifesaving benefits from breast cancer patients?

Renew today!

Subscriber content

Never miss an issue!

Login